Agenovir Corporation

CRISPR gene editing has been a hot area of biotechnology for the past few years despite the absence of data in humans, but the field finally crossed a new threshold with initiation of the first indust

Agenovir Corp. won't use gene-editing to cut out defects or add in missing pieces in a patient's genome like most companies that are working with CRISPR/Cas9 constructs. Instead, it will use the tec

Sanofi has appointed Kathleen Tregoning a member of its executive committee and executive vice president, external affairs – effective Feb. 27, 2017. Tregoning joins Sanofi from Biogen Inc.

Company Changes ABI-SAAB , Walid, MD To: Galapagos NV , CMO (March) From: Shire Pharmaceuticals, Group VP, Global Clin. Dev., Therapeutic Area Head, GI, Endocrinology & Metabolism Phone: +32 15